Baxter International Inc. (BAX) News
Filter BAX News Items
BAX News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BAX News Highlights
- BAX's 30 day story count now stands at 8.
- Over the past 11 days, the trend for BAX's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- AGE, GLP and LLY are the most mentioned tickers in articles about BAX.
Latest BAX News From Around the Web
Below are the latest news stories about BAXTER INTERNATIONAL INC that investors may wish to consider to help them evaluate BAX as an investment opportunity.
3 Attractive Healthcare Dividend Stocks for 2024These names are set to 'age well' considering the sector's major growth tailwind, their valuations and total return potential. |
Healthcare Sector Stocks: Consistent Above-Average Growth And IncomeThe healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records. |
Baxter International (NYSE:BAX) Will Be Hoping To Turn Its Returns On Capital AroundTo find a multi-bagger stock, what are the underlying trends we should look for in a business? Typically, we'll want to... |
Baxter Advances First Intravenous (IV) Bag Recycling Pilot for U.S. HospitalsDEERFIELD, Ill., December 14, 2023--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, announced the completion of the first phase of its intravenous (IV) bag recycling program pilot. Launched in conjunction with Northwestern Medicine, a premier integrated academic health system in Chicago, more than six tons (or 12,000 pounds) of polyvinyl chloride (PVC) IV bag waste — enough to cross the city of Chicago if bags were laid end-to-end — has been suc |
Reasons to Retain Baxter International (BAX) in Your PortfolioBaxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales. |
Baxter to Present at 42nd Annual J.P. Morgan Healthcare ConferenceDEERFIELD, Ill., December 13, 2023--Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. José (Joe) E. Almeida, Baxter’s chairman, president and chief executive officer, is scheduled to present at 10:30 a.m. Pacific Time. |
GLP-1 craze: Buy Baxter, skip Eli Lilly, strategist saysNovo Nordisk (NVO) was named Yahoo Finance's Company of the Year thanks to the success of its diabetes and weight loss drugs, Ozempic and Wegovy. But there are other ways you can play the GLP-1 hype. In the latest edition of "Good Buy or Goodbye," Great Hill Capital Chairman and Managing Member Tom Hayes suggests buying Baxter International (BAX). There are a few reasons why Hayes likes the stock including that it has aggressively sold off, the "valuation is tremendous," and that it has potential catalysts for the stock to recover some of its losses. The stock Hayes is not buying right now is Eli Lilly (LLY). Hayes argues that the stock has already priced in a lot of good news, there will be increased competition, and that there are still questions about what insurance companies will c... |
Baxter Publishes Task Force on Climate-Related Financial Disclosures (TCFD) Report and Is Named to Dow Jones Sustainability Index North AmericaDEERFIELD, Ill., December 11, 2023--Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its first report aligned with the Task Force on Climate-related Financial Disclosures (TCFD) recommendations, which were recently incorporated into the International Sustainability Standards Board Standards. The TCFD framework is designed to help improve climate-related disclosure that is relevant to Baxter’s investors and other key stakeholders in the areas of governance, strategy, |
Spectral Medical Provides November Tigris Trial Update79 patients enrolled TORONTO, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today provided an update for the month of November on the Company’s Tigris trial, a Phase 3 follow-on study evaluating the use of Polymyxin B Hemoperfusion (“PMX”) in a randomized controlled trial of adults treated for endotoxemia and septic shock. 79 patients enrolled to date an |
The Baxter International Foundation and UNICEF Partner to Expand Access to Safe Water and Sanitation in EgyptDEERFIELD, Ill. & NEW YORK, November 28, 2023--The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), and UNICEF, today announced a partnership to improve access to safe drinking water and sanitation in five water-challenged regions in Egypt. Supported by a $2.5 million grant from the Foundation, this three-year initiative aims to implement climate-smart water, sanitation and hygiene (WASH) programming for thousands of people in Upper Egypt’s governor |